FDA Approves Biosimilar Ogivri for Breast, Stomach Cancers
Ogivri is approved to treat HER2+ breast and gastric or gastroesophageal junction adenocarcinoma cancers
Mortality Up for Some Cancers in Urban-Dwelling Native Americans
Urban American Indians and Alaskan Natives with cancer have significantly higher comorbidity burden
Over 5 Percent of Incident Cancer Due to Diabetes, High BMI
In 2012, 5.6 percent of all incident cancers due to combined effects of diabetes, high BMI
Unapproved Drugs Identified in Androgen Receptor Modulators
Most of the 44 products sold via the internet contained unapproved drugs and substances
Value-Based Payment Modifier Not Tied to Practice Performance
Performance differences between practices narrowed after adjustment for patient characteristics
Clinician Denial of Patient Requests Impacts Satisfaction
Worse satisfaction in association with denial of request for referral, pain meds, other meds, lab tests
Sex, Race, Age Disparities in Survival for HPV-Linked Cancer
Whites have consistently higher five-year survival than blacks for all cancers across all age groups
Risk of ≥CIN3 Drops With Negative HPV, Cytology Co-Tests
Decrease in 5-year ≥CIN3 risks after each successive negative round of HPV, cytology co-testing
Less Frequent Biopsy May Be Option in Prostate Cancer Care
Consequences of biennial versus annual biopsies similar during active surveillance
Coffee Consumption Appears to Provide More Benefit Than Harm
Largest relative reduction in health outcomes seen with intake of three to four cups/day versus none
